Status:
UNKNOWN
Treatment of Hyperpyrexia and in the Pediatric Emergency Department (FEVER_ED)
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Fever
Eligibility:
All Genders
6-20 years
Brief Summary
Fever represents the main cause of admission to the emergency room in older people pediatric. It occurs in the presence of a wide range of pathologies, from infectious forms (the most common, viral or...
Eligibility Criteria
Inclusion
- Pediatric patients (aged between 6 months 0 and 20 years)
- fever (T \> 38°C) with/without associated symptoms, treated with standard antipyretic drugs orally (paracetamol, ibuprofen or paracetamol/ibuprofen combination)
- who have expressed their consent to participate in the study.
Exclusion
- age \<6 months or \>20 years;
- patients who did not express consent to participate in the study
Key Trial Info
Start Date :
December 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06194383
Start Date
December 22 2023
End Date
December 1 2024
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy, 00168